The Weekly Roundup: March 31-April 4

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Dermatology Conferences and Meetings Calendar: April 2025

Dermatology Times has compiled a list of dermatological meetings taking place during the month of April.

Optimizing Vitiligo Care: Key Expert Takeaways

The significance of patient education and setting realistic expectations for the often-slow process of repigmentation in vitiligo treatment was a key focus of the discussion.

High-Intensity Ultrasound Device Is Suitable for Facial Acne Scars in Asian Patients

Nearly all patients saw improvements in small, medium, and large depressions on the cheeks and temples with just a singular treatment session.

Challenges and Future Directions in Microbiome Engineering

Microbiome engineering offers strategies to modulate the skin microbiome, including non-targeted approaches like probiotics and targeted approaches like phage therapy.

Salix purpurea Shampoo Supports Scalp Health in Patients with Dandruff and Erythema

2% and 4% formulations of the product were effective and tolerable for patients with varying scalp conditions.

New Data on the Perception of Pregnancy-Related Skin Changes

Misinformation from outside sources creates unrealistic expectations for pregnancy and postpartum skin conditions like hyperpigmentation.

Guselkumab Shows Strong Response in Long-Term Subtype Psoriasis Study

Bio-naïve patients and those without comorbidities had the highest treatment success rates with guselkumab.

New Research Highlights Underreported Risks of Deprescribing

Researchers call for standardized methods to assess and report ADWEs in deprescribing trials to ensure reliable data and clinical confidence.

Quality of Life Improvements after Psoriasis Cal/BD Aerosol Foam Treatment

Positive changes in DLQI scores were observed after 4 weeks of therapy as well as the 6-month follow-up.

Exploring the 2025 Revolutionizing Atopic Dermatitis (RAD) Annual Meeting Agenda

Get a glimpse of the cutting-edge atopic dermatitis research, breakthroughs, and insights to be presented at the 7th RAD Annual Meeting, June 6-7, 2025.

Hand Eczema Prevalence and Patterns in East Greenland Similar to Nordic and European Trends

Hand eczema affects 22.4% of adults in East Greenland, with prevalence, severity, and risk factors mirroring trends other populations.

Atopic Dermatitis Insights on Global Prevalence, Health Care Implications, and the Impact of COVID-19

Researcher Jiyeon Oh shares results of a recent study that confirm the prevalence of AD is stable, but disease burden is rising.

Multicenter Study Sheds Light on Pediatric MMP

The study stated early recognition and aggressive treatment of childhood-onset MMP are essential to prevent permanent scarring.

Researchers Report Rare Case of Squamous Cell Carcinoma in Sun-Shielded Area in Epidermodysplasia Verruciformis

Researchers reported the case of a 28-year-old woman with epidermodysplasia verruciformis who developed SCC on a sun-protected scalp.

Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon Oh

Jiyeon Oh’s research confirms that a personalized approach is needed to treat all complexities associated with AD.

Reduced Cardiovascular Risk with Biologics in Psoriasis and PsA

Unlike biologics, nonbiologic systemic therapies showed a neutral or slightly increased cardiovascular risk, raising concerns about their long-term safety.

Guselkumab Demonstrates Impact on Both Disease Progression and Symptoms in Psoriatic Arthritis

Tremfya is the first IL-23 inhibitor to significantly improve both symptoms and structural damage in active psoriatic arthritis.

The Power of Art in Clinical Spaces

Studies show that exposure to meaningful artwork can lower blood pressure and enhance mental clarity in patients.

Allergan Aesthetics' Effort to Create a Unified Vocabulary for Skin Quality

Sherket Peterson, PhD, spoke to Dermatology Times about Allergan’s recent research and plan to launch a universal skin quality index.

New Study Compares Infection Risk of AD Systemic Therapies

The study found dupilumab-treated patients had the highest probability of remaining infection-free over 52 weeks.

Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care

A cross-sectional survey revealed that many patients with HS are dissatisfied with treatment options, with gaps in knowledge about FDA-approved therapies.

Bridging the Communication Gap Between Providers and Patients Through the Skin Quality Index

Allergan’s latest initiative hopes to empower both patients and clinicians while advancing industry standards, according to Sherket Peterson, PhD.